Corning Inc. has launched Corning Viridian Vials, expanding its pharmaceutical glass-packaging portfolio. Viridian Vials are designed to improve filling-line efficiency by up to 50% while reducing vial-manufacturing carbon-dioxide-equivalent (CO2e) emissions by up to 30%.

As demand for Injectable medicines rises, pharmaceutical manufacturers are looking to increase production efficiently while reducing the environmental impact of their supply chain. According to the company, Viridian Vials use 20% less glass material than conventional glass vials, with no impact on the quality or safety of the vial. This reduction in glass material lowers manufacturing and transportation-related emissions by up to 30%, according to the company. In addition, Viridian’s low-friction external coating is designed to minimize cracks, breaks, and cosmetic rejects while improving filling-line efficiency by up to 50%.

“With Viridian, we’ve created a drop-in solution that’s compatible with today’s equipment and standards – and that helps our customers achieve their sustainability goals,” said Verkleeren.
West Pharmaceutical Services will be the exclusive distributor of Viridian Vial Technology. Corning’s ongoing collaboration with West brings together two industry leaders with a shared commitment to using resources responsibly to help create a healthier, more sustainable world.